US Patent Issued to Abraxis BioScience on June 10 for "Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin" (California, New Jersey Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,860, issued on June 10, was assigned to Abraxis BioScience LLC (Summit, N.J.).

"Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin" was invented by Neil P. Desai (Pacific Palisades, Calif.) and Shihe Hou (Millington, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides methods of treating a CNS disorder (such as glioblastoma and epilepsy) in an individual, comprising systemically (e.g., intravenously or subcutaneously) administering to the individual an effective amount of a composition comprising nanoparticles comprising an mTOR inhibitor (such...